ALFA Finder| Revenue growth | H2-FY26 up 23.8% YoY; FY26 consolidated revenue up 5.7% YoY. |
|---|---|
| Margins | EBITDA margins compressed from 14.0% to 12.6% YoY in H2-FY26. |
| Order book | Open orders exceeding ₹6,526 Lacs provide robust visibility. |
| Demand visibility | Advance and open orders exceeding ₹6,526 Lacs as of March 2026. |
| Management confidence | Confident in strong growth trajectory backed by ₹6,526 Lacs order visibility. |
Growth
H2-FY26 Revenue grew 23.8% YoY; EBITDA grew 10.9%. Full year FY26 consolidated revenue reached ₹21,482.9 Lacs.
Outlook
Commissioning EZRM SEZ facility in 2027; aiming for #1 CRDMO leadership in Nutraceuticals by 2030 with 60% manufacturing revenue.
Risks
Global supply chain disruptions, pricing corrections in key products, and US tariff policy uncertainties impacting export demand.
Earnings Call filed with BSE, BSE: 544442. Summary written with AI assistance from the document.
Chemkart India Ltd: key numbers
- Share price
- ₹226.25
- Market cap
- ₹273.7 Cr
- Revenue (annual)
- ₹214.8 Cr
- Net profit (annual)
- ₹19.66 Cr
- P/E (TTM)
- 13.9×Sector 41.3×
- Promoter holding
- 74.88%
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemkart India Ltd
All →Chemkart India Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
Chemkart India Other Announcement
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹22.6 Cr · +121.6% YoY
Chemkart India Acquisition Worth ₹0.98 Cr
Chemkart invests Rs. 0.98 Crore in its WOS Easy Raw Materials for working capital. The related-party transaction was approved at arm's length on 27 October 2026.
- Value
- ₹0.98 Cr
Chemkart India Capital Structure Change
Chemkart India invests Rs. 0.98 Crore in its wholly-owned subsidiary Easy Raw Materials via a rights issue. The funds support commissioning of the subsidiary's manufacturing unit.
- Value
- ₹0.98 Cr
Chemkart India Other Announcement
Chemkart India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholder categories and promoter holdings.